JP2005511626A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511626A5
JP2005511626A5 JP2003544049A JP2003544049A JP2005511626A5 JP 2005511626 A5 JP2005511626 A5 JP 2005511626A5 JP 2003544049 A JP2003544049 A JP 2003544049A JP 2003544049 A JP2003544049 A JP 2003544049A JP 2005511626 A5 JP2005511626 A5 JP 2005511626A5
Authority
JP
Japan
Prior art keywords
dysfunction
sexual dysfunction
sexual
female
male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003544049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511626A (ja
JP4484517B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036117 external-priority patent/WO2003042213A1/en
Publication of JP2005511626A publication Critical patent/JP2005511626A/ja
Publication of JP2005511626A5 publication Critical patent/JP2005511626A5/ja
Application granted granted Critical
Publication of JP4484517B2 publication Critical patent/JP4484517B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003544049A 2001-11-14 2002-11-12 ホスホジエステラーゼ阻害剤として有用な置換された四環式ピロロキノロン誘導体 Expired - Fee Related JP4484517B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33297701P 2001-11-14 2001-11-14
PCT/US2002/036117 WO2003042213A1 (en) 2001-11-14 2002-11-12 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors

Publications (3)

Publication Number Publication Date
JP2005511626A JP2005511626A (ja) 2005-04-28
JP2005511626A5 true JP2005511626A5 (https=) 2006-01-26
JP4484517B2 JP4484517B2 (ja) 2010-06-16

Family

ID=23300709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003544049A Expired - Fee Related JP4484517B2 (ja) 2001-11-14 2002-11-12 ホスホジエステラーゼ阻害剤として有用な置換された四環式ピロロキノロン誘導体

Country Status (14)

Country Link
US (1) US6686349B2 (https=)
EP (1) EP1448562B1 (https=)
JP (1) JP4484517B2 (https=)
CN (1) CN1280292C (https=)
AT (1) ATE368040T1 (https=)
CA (1) CA2467269C (https=)
CY (1) CY1107747T1 (https=)
DE (1) DE60221425T2 (https=)
DK (1) DK1448562T3 (https=)
ES (1) ES2289159T3 (https=)
MY (1) MY128241A (https=)
PT (1) PT1448562E (https=)
TW (1) TWI264437B (https=)
WO (1) WO2003042213A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629299A1 (de) * 1996-07-20 1998-01-22 Agfa Gevaert Ag Verfahren und Vorrichtung zum Aufnehmen einer Bildinformation
DE60317684T4 (de) * 2002-06-19 2011-06-22 Janssen Pharmaceutica N.V., 2340 SUBSTITUIERTE 2,4-DIHYDROPYRROLOc3,4BÜCHINOLIN-9-ONDERIVATE, DIE SICH ALS PHOSPHODIESTERASEINHIBITOREN EIGNEN
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP1914235A1 (en) * 2006-10-10 2008-04-23 Universite de Lille 2 Droit et Santé Chiral tetra-hydro beta-carboline derivatives and applications thereof as antiparasitic compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN110862391B (zh) * 2019-11-13 2020-09-25 株洲千金药业股份有限公司 一种他达拉非杂质g的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH625521A5 (https=) 1976-10-15 1981-09-30 Sandoz Ag
US6143746A (en) 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
DE4436509A1 (de) 1994-10-13 1996-04-18 Hoechst Schering Agrevo Gmbh Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
UA74826C2 (en) 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
UA72611C2 (uk) * 2000-05-17 2005-03-15 Орто-Макнейл Фармацевтикал, Інк. Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази

Similar Documents

Publication Publication Date Title
JP2005511626A5 (https=)
IL178758A0 (en) Use of flibanserin in the treatment of premenstrual and other female sexual disorders
TWD151707S1 (zh) 射精促進具(二)
TWD151710S1 (zh) 射精促進具(五)
WO2004098517A8 (en) Methods of hormonal treatment utilizing extended cycle contraceptive regimens
WO2005099366A3 (en) Sexual intercourse simulation device
DE202005000061U1 (de) Hilfsgerät zum Fördern der sexuellen Erregung
JP2005526790A5 (https=)
WO2003088880A3 (en) Condom
ME03499B (me) Farmaceutske kombinacije koje sadrže testosteron i tadalafil u liječenju ženske seksualne disfunkcije
CN207886335U (zh) 一种物理持久延时避孕套
CN2464274Y (zh) 阳具疲软用阴茎盔
AU2003212569A8 (en) Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis
RU104062U1 (ru) Устройство для увеличения потенции
CN2226936Y (zh) 夫妻康复器
CN200991339Y (zh) 可扩大保护面积的防护套
CN2210634Y (zh) 增强性爱快感欢乐器
JP3223533U (ja) 軟質棘を有する陰茎リング
CN2256714Y (zh) 理疗避孕套
CN2494189Y (zh) 一种振阳托
CN2210635Y (zh) 男士康乐环
CN2198890Y (zh) 促潮茎
JP1783698S (ja) 性行為補助具
CN202061047U (zh) 一种新型自慰器
CN2595191Y (zh) 保健裤衩